Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 3374-3379, June 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaden, D.
Right arrow Articles by Sager, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaden, D.
Right arrow Articles by Sager, R.

Spontaneous Mutation Rates of Tumorigenic and Nontumorigenic Chinese Hamster Embryo Fibroblast Cell Lines1

Debra Kaden2, Inder K. Gadi, Lee Bardwell3, Rebecca Gelman and Ruth Sager4

Divisions of Cancer Genetics [D. K., L. B., R. S.] and Biostatistics and Epidemiology [R. G.], Dana-Farber Cancer Institute, Boston, Massachusetts 02115; Department of Surgery, UMDNJ, RWJ Medical School, Brunswick, NJ 08903 [I. K.]

The genomic stability of a series of nontumorigenic, tumorigenic, and tumor-derived Chinese hamster embryo fibroblastic (CHEF) cell lines was compared by examining their rates of spontaneous mutation at the hypoxanthine-guanine phosphoribosyl transferase (hprt) locus, using thioguanine resistance for selection of mutants. The spontaneous mutation rates were 1.1 x 10-6 mutations/cell/generation in the non-tumorforming CHEF/18 cell line and 4.9 x 10-6 in the tumorigenic CHEF/16 cells. Three tumorigenic and tumor-derived CHEF cell lines derived from CHEF/18 (J132 3–2 T3L, focus 2, focus 3) and two lines (16–2 Tuk 4 and 204 Bu50 Tuk 2) derived from CHEF/16 were chosen on the basis of their karyotypes, which demonstrated a considerable level of chromosomal rearrangement. Mutation rates of four of these five lines ranged from 1.2 x 10-6 to 8.9 x 10-6 mutations per cell per generation. Only the fifth line, 16-2 Tuk 4, showed a significantly elevated rate of mutation as compared with the nontumorigenic CHEF/18 cell line. Thus, we have found no simple correlation between spontaneous mutation rate and the malignant phenotype, and we conclude that mutation rate per se is not a sensitive index of malignancy. In addition, we have compared three methods of calculating mutation rate and find that they rank the cell lines in the same order, but each stresses a different aspect of the distribution and therefore produces different estimates of the mutation rate.

1 Supported by NIH Grant CA-39814.

2 Present address: Meta Systems, Inc., 58 Charles Street, Cambridge, MA 02141.

3 Present address: University of California, Stanford, CA 94305.

4 To whom requests for reprints should be addressed.

Received 4/ 5/88. Revised 2/16/89. Accepted 3/17/89.




This article has been cited by other articles:


Home page
Cancer Res.Home page
H. Rubin and G. R. Anderson
Correspondence re: G. Anderson et al., Intrachromosomal Genomic Instability in Human Sporadic Colorectal Cancer Measured by Genome-Wide Allelotyping and Inter-(Simple Sequence Repeat) PCR. Cancer Res., 61: 8274-8283, 2001.
Cancer Res., November 1, 2002; 62(21): 6350 - 6351.
[Full Text] [PDF]


Home page
ScienceHome page
I Nishisho, Y Nakamura, Y Miyoshi, Y Miki, H Ando, A Horii, K Koyama, J Utsunomiya, S Baba, and P Hedge
Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients
Science, August 9, 1991; 253(5020): 665 - 669.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.